Abstract:Dendritic cells (DCs) are the most potent antigen presenting cells and possess an incomparable ability to activate and instruct T cells, which makes them one of the cornerstones in the regulation of the cross-talk between innate and adaptive immunity. Therefore, a deep understanding of DC biology lays the foundations to describe and to harness the mechanisms that regulate the development of the adaptive response, with clear implications in a vast array of fields such as the study of autoimmune diseases and the development of new vaccines. However, the great difficulty to obtain large quantities of viable non-activated DCs for experimentation have considerably hindered the progress of DC research. Several strategies have been proposed to overcome these limitations by promoting an increase of DC abundance in vivo, by inducing DC development from DC progenitors in vitro and by generating stable DC lines. In the past years, we have described a method to derive immortalized stable DC lines, named MutuDCs, from the spleens of Mushi1 mice, a transgenic mouse strain that express the simian virus 40 Large T-oncogene in the DCs. The comparison of these DC lines with the vast variety of DC subsets described in vivo has shown that all the MutuDC lines that we have generated so far have phenotypic and functional features of type 1 conventional DCs (cDC1s). With the purpose of deriving DC lines with characteristics of type 2 conventional DCs (cDC2s), we bred a new Batf3-/- Mushi1 murine line in which the development of the cDC1 subset is severely defective. The new MutuDC line that we generated from Batf3-/- Mushi1 mice was phenotypically and functionally characterized in this work. Our results demonstrated that all the tested characteristics of this new cell line, including the expression of subset-determining transcription factors, the profile of cytokine production and the ability to present antigens, are comparable with the features of splenic CD4- cDC2s. Therefore, we concluded that our new cell line, that we named CD4- MutuDC2 line, represents a valuable model for the CD4- cDC2 subset.

Newly found rat CD103 dendritic cells are the highly immunogenic conventional DC2 subpopulation, corresponding to the known DC subsets in mice and humans.

Mouse thymic dendritic cell subpopulations

Mouse Plasmacytoid Cells

Antigen Presenting Properties of a Myeloid Dendritic-Like Cell in Murine Spleen

Cd11c+B220+Gr-1+ Cells in Mouse Lymph Nodes and Spleen Display Characteristics of Plasmacytoid Dendritic Cells

Small Intestinal Cd103(+) Dendritic Cells Display Unique Functional Properties That Are Conserved Between Mice and Humans

Murine Thymic Plasmacytoid Dendritic Cells

Characteristics of resident dendritic cells in various regions of rat periodontal ligament

Mouse Plasmacytoid Cells: Long-Lived Cells, Heterogeneous In Surface Phenotype And Function, That Differentiate Into Cd8(+) Dendritic Cells Only After Microbial Stimulus

Generation of Rat Spleen-Derived Dendritic Cells and Their Biological Characteristics

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens

Isolation of mouse thymic dendritic cell precursors.

Cd4 and Cd8 Expression by Dendritic Cell Subtypes in Mouse Thymus and Spleen

Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells

The Equivalents of Human Blood and Spleen Dendritic Cell Subtypes Can Be Generated in Vitro from Human CD34 + Stem Cells in the Presence of Fms -Like Tyrosine Kinase 3 Ligand and Thrombopoietin

Cross-species analyses reveal RORγt-expressing dendritic cells are a lineage of antigen presenting cells conserved across tissues

Distinct functional capacities of mouse thymic and splenic dendritic cell populations

Novel Insights into the Relationships Between Dendritic Cell Subsets in Human and Mouse Revealed by Genome-Wide Expression Profiling

The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells.

Dendritic cell inhibitory receptor 4 (DCIR4) is preferentially expressed on inflammatory and patrolling monocytes

Establishment and Characterization of a Functionally Competent Type 2 Conventional Dendritic Cell Line